Hesai
- Market cap
- 2.51B
- P/E (TTM)i
- 31.75
- P/Bi
- 1.88
- EPSi
- 0.44
- Div yieldi
- 0.00%
- 52W posi
- 11%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- Total institutional ownership rose 1.5 percentage points.
Institutional ownership
- Held by institutions
- 53.24% +1.49pp
- Institutions
- 212
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-05-26
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
22 filings tracked · 5 buys · 3 sells
| Name | Role | Stake |
|---|---|---|
| Kai Sun | Co-Founder, Chief Scientist & Director | 5.87% |
| Shaoqing Xiang | Co-Founder & CTO | 5.76% |
| Yifan Li | Chief Executive Officer | 5.65% |
| Cailian Yang | VP of Operations & Director | 0.08% |
| Peng Fan | Chief Financial Officer | 0.06% |
| Yi Zhang | Independent Director | 0.01% |
| Jie Chen | Independent Director | 0.01% |
| Jia Ren | Independent Non-Executive Director | -- |
| Hui Wang | Independent Director | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-18 | Peng Fan | Chief Financial Officer | Derivative Exercise and Retained | +50,000 | -- |
| 2026-03-24 | Kai Sun | Co-Founder, Chief Scientist & Director | Other Derivative Acquisition | +1,256,000 | -- |
| 2026-03-24 | Yifan Li | Chief Executive Officer | Other Derivative Acquisition | +1,256,000 | -- |
| 2026-03-24 | Shaoqing Xiang | Co-Founder & CTO | Other Derivative Acquisition | +1,256,000 | -- |
| 2026-03-24 | Hui Wang | Independent Director | Other Derivative Acquisition | +52,520 | -- |
| 2026-03-17 | Yi Zhang | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Kai Sun | Co-Founder, Chief Scientist & Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Peng Fan | Chief Financial Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Yifan Li | Chief Executive Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Shaoqing Xiang | Co-Founder & CTO | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Jia Ren | Independent Non-Executive Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Cailian Yang | VP of Operations & Director | Initial Statement of Beneficial | 0 | -- |
| 2025-03-12 | Kai Sun | Co-Founder, Chief Scientist & Director | Intent to Sell (Form 144) | -1,028,325 | $22.55 |
| 2025-03-12 | Yifan Li | Chief Executive Officer | Intent to Sell (Form 144) | -1,008,101 | $22.55 |
| 2025-03-12 | Shaoqing Xiang | Co-Founder & CTO | Intent to Sell (Form 144) | -1,007,534 | $22.55 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 06:32:28 · For reference only, not investment advice and not tailored to your situation.